Tag Archives: IRB

ORA Office Overview

August 30, 2020

The Office for Research Administration encompasses many individual offices, each of which retain expertise in different areas of the research process. Your first point of contact will usually be your local RAS representative. They will help you determine which of the other touchpoints are necessary to submit a grant application, conduct a clinical trial, or […]

Posted in ORA | Also tagged , , , , , , , , , , | Comments closed

IRB Updates

August 29, 2020

We updated out COVID-19 guidance to include links to FDA guidance re: acceptable consent methods for participants in isolation. We also made various minor updates throughout. Important updated External IRB guidelines on what to submit to Emory IRB at time of continuing review and after major reportable events. Guidelines to avoid delay when submitting study […]

Posted in IRB | Also tagged , , | Comments closed

OHRP Exceptions to Single IRB Review

December 3, 2019

On November 22, 2019, OHRP announced that federally-funded multisite studies with IRB approval before 1/20/20, do not need to move to single IRB review, per the revised Common Rule. OHRP made this announcement after receiving feedback from institutions pointing out that transitioning ongoing studies from local IRBs to a single IRB would result in unnecessary […]

Posted in IRB | Also tagged , , , , , , | Comments closed

IRB Update- New eIRB System

July 30, 2019

Data/Study Migration is an important part of our System Upgrade project. This is where we move existing study information from the old to the new system. It is important that we can move away from our old system completely as quickly as possible. Data/Study migration is always a challenge, but our approach is designed to minimize […]

Posted in IRB | Also tagged , , | Comments closed

IRB Recruitment Spotlight

December 21, 2018

Remember, “cold calling” is generally prohibited as a recruitment strategy, even if the IRB approves your review of the Clinical Data Warehouse (e.g.) to find potential subjects. Initial contact must come from a treating provider, unless the patient has authorized contact via Emory Healthcare’s “front door authorization” (see flag in the medical record). Requests for […]

Posted in IRB | Also tagged , | Comments closed

The Revised Common Rule is Almost Here!

December 21, 2018

Effective January 21, 2019, human subjects research is subject to revised regulations. *Please note that FDA has not yet harmonized, so parts of the new Rule cannot be applied to FDA-regulated research.* Details are available in our recent webinars here: http://irb.emory.edu/Training/webinars.html. What will you see in eIRB? If you submit, or edit a new submission, after […]

Posted in IRB | Also tagged , , , | Comments closed

Single IRB Review Reminder

December 21, 2018

If your NIH RFA will involve collaborating sites, and NIH requires the use of a single IRB (“sIRB”), we remind you to consult with the Emory IRB very early on in the grant-writing process, and to not submit your sIRB plan without our prior review. We also remind you that reliance on an independent IRB is […]

Posted in IRB | Also tagged , , , , | Comments closed

NIH ALERT: New NIH Submission Requirements Effective January 25, 2018

January 2, 2018

To all Investigators proposing human subjects research to the NIH, For NIH submissions with due dates on or after January 25, 2018, it is imperative to make an accurate determination of whether your study meets the NIH definition of a clinical trial.  The NIH has broadly defined a “clinical trial” resulting in stringent requirements—some are […]

Posted in Announcements, IRB, NIH, RAS | Also tagged , , , , , , , | Comments closed

The Common Rule is Revised – but under temporary moratorium

February 23, 2017

DHHS’s revised “Common Rule” governing human subjects research was finally published, and will become effective January 19, 2018 (except for the single-IRB requirement for cooperative research, which is two years later). However, there is a 60 day moratorium in effect at the moment. For summaries of the very significant changes (including removal of continuing review […]

Posted in IRB | Also tagged | Comments closed